Verona Pharma Release: Further Clinical Data Highlighting the Significant Bronchodilator Activity of Novel Dual PDE3/4 Inhibitor RPL554 Presented at American Thoracic Society International Conference
5/21/2013 10:04:33 AM
More...
|
Verona Pharma to Present Clinical and Pre-Clinical Data Highlighting the Significant Bronchodilator Activity of Novel Dual PDE3/4 Inhibitor RPL554 at Upcoming American Thoracic Society International Conference
5/16/2013 10:06:46 AM
More...
|
Verona Pharma Release: Clinical and Scientific Advisory Board Formed to Help Guide Future Development of RPL554
4/29/2013 9:59:25 AM
More...
|
Verona Pharma: FY 2012 Results
4/10/2013 9:57:15 AM
More...
|
Verona Pharma Release: RPL554 Demonstrates Airway Anti-Inflammatory Activity
3/5/2013 10:53:07 AM
More...
|
Verona Pharma Release: $1.7 Million Placing and $7.9 Million Equity Finance Facility
1/31/2013 11:05:56 AM
More...
|
Verona Pharma: Interim Results for the Six Months Ended 30 June2012
9/14/2012 10:00:29 AM
More...
|
New Data on Verona Pharma's RPL554 in COPD to be Presented at ERS Annual Congress
9/4/2012 11:51:28 AM
More...
|
U.S. Patent Granted for Verona Pharma's RPL554
8/28/2012 10:18:43 AM
More...
|
Verona Pharma Initiates Dosing in Clinical Trial to Investigate Anti-inflammatory Properties of RPL554
7/9/2012 9:35:52 AM
More...
|
|